Completed from United Kingdom
I signed up for the Pharmacoeconomics course hoping to get a solid grounding before my first role in a pharma company, and it delivered. The content was clear and the examples – like the budget impact model for a new vaccine – were spot‑on. I especially liked the practical sessions where we built a simple Markov model in R; it made the theory feel usable. The course material was relevant and up‑to‑date, though a few extra case studies would have been nice. Still, I walked away with real skills I can put on my CV and feel ready to tackle real‑world economic evaluations.
The Pharmacoeconomics course at Stanmore School of Business perfectly aligned with my goal to transition into health‑policy analysis. The modules on cost‑effectiveness modeling gave me a step‑by‑step Excel framework that I immediately applied to a real‑world case study on an oncology drug. The lecture slides were concise, and the supplementary reading on health‑technology assessment was up‑to‑date with current NICE guidelines. I left the course confident in preparing budget‑impact analyses for my employer, and the interactive assignments reinforced the practical skills I needed. Overall, a top‑notch learning experience that exceeded my expectations.
Wow! This course blew me away with its depth and energy. I wanted to understand how drug pricing decisions are made in emerging markets, and the lectures on willingness‑to‑pay thresholds gave me exactly that insight. The hands‑on workshop where we simulated a cost‑utility analysis for a diabetes medication using Python was thrilling – I can now build my own models from scratch! The study material was beautifully organized, and the instructor’s enthusiasm made every concept click. I’m now confidently presenting pharmacoeconomic reports at my workplace, and I can’t thank Stanmore enough for such an empowering experience.
The Pharmacoeconomics program provided a comprehensive and detailed overview that matched my learning objectives perfectly. The curriculum covered everything from basic concepts of incremental cost‑effectiveness ratios to advanced topics like probabilistic sensitivity analysis. I found the case study on a malaria intervention especially useful; it illustrated how to translate clinical outcomes into economic terms using real data from South Africa. The course packs were well‑structured, and the supplemental webinars on health‑policy applications added great value. While the pacing was a bit fast for some sections, the overall experience was highly satisfactory and equipped me with practical tools for my role as a health economist.
